- Julie Kim proposed as representative director, president and CEO effective June 24, 2026; Christophe Weber to retire that day.
- Bruce Broussard, Koichiro Kimura and Paul Stoffels proposed as new external directors at the June 24, 2026 shareholders meeting; six current external directors will retire.
- Internal slate includes Milano Furuta (CFO) and Andrew Plump (President, Research & Development).
- Audit & Supervisory Committee candidates (two-year tenure) are Kimberly Reed, Bruce Broussard and Koichiro Kimura; non-Audit directors have one-year tenures.
Board changes and timetable
Takeda's Board will propose director candidates at the 150th Ordinary General Meeting on June 24, 2026; Julie Kim is proposed as a board candidate and, if elected, will be appointed representative director, president and CEO immediately after the meeting, and current CEO Christophe Weber will retire the same day; six current external directors (Jean Luc Butel, Ian Clark, Yoshiaki Fujimori, Koji Hatsukawa, Emiko Higashi and Michel Orsinger) are to retire while other board members are proposed for re-election.
New external candidates
Bruce Broussard, Koichiro Kimura and Paul Stoffels are proposed to join the Board if approved: Broussard is interim CEO of HP Inc and former CEO of Humana; Kimura is senior advisor to Eurasia Group and former PwC Japan chairman; Stoffels is co-founder and former CEO of Galapagos and former chief scientific officer at Johnson & Johnson.
Internal slate and committee candidates
Non-Audit director candidates include Julie Kim, Milano Furuta (CFO), Andrew Plump (President, Research & Development), Masami Iijima (chair of the Board meeting), Steven Gillis, John Maraganore, Miki Tsusaka and Paul Stoffels (also a candidate as substitute Audit and Supervisory Committee member); Audit and Supervisory Committee candidates are Kimberly Reed, Bruce Broussard and Koichiro Kimura.
Tenures and next steps
Non-Audit directors have one-year tenures and Audit and Supervisory Committee directors two-year tenures; specific director roles, committee memberships and Nomination and Compensation Committee composition will be determined at Board and Audit and Supervisory Committee meetings after the shareholders meeting.
